Dr. Martens plc (LON:DOCS)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 658.65M |
| Revenue (ttm) | 785.00M -2.6% |
| Net Income | 15.30M -48.0% |
| EPS | 0.02 -49.2% |
| Shares Out | 967.30M |
| PE Ratio | 44.04 |
| Forward PE | 14.55 |
| Dividend | 0.03 (3.88%) |
| Ex-Dividend Date | Mar 5, 2026 |
| Volume | 4,024,177 |
| Average Volume | 1,621,974 |
| Open | 68.00 |
| Previous Close | 65.70 |
| Day's Range | 65.90 - 68.88 |
| 52-Week Range | 43.02 - 100.87 |
| Beta | 0.24 |
| RSI | 29.70 |
| Earnings Date | Jan 23, 2026 |
About Dr. Martens
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.
Financial StatementsNews
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call January 27, 2026 3:30 AM ESTCompany ParticipantsOnyeije Nwokorie - CEO & Executive DirectorGiles...
Dr Martens sales slip after pulling back from discounts
The firm saw shares dip in early trading as it said revenues were set to be broadly flat for the current year.
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
Chief Executive Ije Nwokorie said the EMEA market continued to be challenging, and that the company had taken a more disciplined promotional stance there.
UK Stock Market News: Dr Martens, Sage, Mitie
Stamping out discounting hjelps Dr Martens profits, Sage's recurring revenues tick higher, opportunities keep growing for Mitie
Dr. Martens PLC (DOCMF) Half Year 2026 Earnings Call Highlights: A Turnaround to Profit and ...
Dr. Martens PLC (DOCMF) Half Year 2026 Earnings Call Highlights: A Turnaround to Profit and Strategic Expansion
Trump tariffs force Dr Martens To hike US prices - but boot firm says it is still on track with full-year forecast
Dr Martens had previously pledged to keep prices on hold in 2025 despite high tariffs, but said it would need to make increases from the start of 2026.
Half Year 2026 Dr Martens PLC Earnings Call Transcript
Half Year 2026 Dr Martens PLC Earnings Call Transcript
Dr. Martens plc (DRMTY) Q2 2026 Earnings Call Transcript
Dr. Martens plc 2026 Q2 - Results - Earnings Call Presentation
Shabana Mahmood puts the signs up: Britain is full. No blacks, no dogs, no Irish
We had always given sanctuary to those who needed it, she said, only now we would kick them out as soon as possible Shabana Mahmood was in a determined frame of mind. It was time to get serious. No mo...
Bank of England finance chief Afua Kyei tops list of influential black Britons
Kyei leads power list showcasing black role models across business, science, technology and the arts Afua Kyei, the finance chief of the Bank of England, has been named the UK’s most influential black...
Dr. Martens: Iconic Brand At A Potential Bargain
Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a con...
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q4 2025 Earnings Conference Call June 5, 2025 2:00 AM ET Company Participants Giles Wilson - CFO & Director Onyeije Ogueri Nwokorie - CEO & Chief Brand Officer Onyeije Og...
Dr Martens forecasts return to profit growth, shares jump
British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...
Dr. Martens Selects Amperity to Transform Customer Data Strategy
LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie - CEO Giles Wilson - CFO Conference Call Participants Kate Calvert - I...
Dr Martens' shares jump 15% on new CEO's start date despite drop in first half sales
Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker
Dr Martens sees strong US holiday sales, cuts inventory and debt
Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...
Stock Picks From Seeking Alpha's October 2024 New Analysts
In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...
Dr. Martens: Struggling To See The Downside At This Valuation
Dr. Martens is a strong brand with healthy cash flows and a cheap valuation, making it an attractive investment opportunity. Growth potential lies in geographic expansion and product line diversificat...
Dr. Martens shares plunge to record lows on discount bulk sale via Goldman Sachs
Dr. Martens' investors sold 70 million shares in the bootmaker at a price of 57.85 pence per share, in what marks a 10% discount on its closing share price on Thursday
Dr. Martens plc. (DOCMF) H2 2024 Earnings Call Transcript
Dr. Martens plc. (OTCPK:DOCMF) H2 2024 Earnings Conference Call May 30, 2024 4:30 AM ET Corporate Participants Kenneth Wilson - Chief Executive Officer Giles Wilson - Chief Financial Officer Conferenc...
Dr Martens will cut up to £25m in costs to counter weak US sales
British footwear brand does not rule out job losses, while profits fall by 43% to £97m
Dr. Martens Stock Plummets on Downbeat US Outlook
U.K.-listed Dr. Martens PLC issued a downbeat outlook for its U.S. sales on Tuesday, noting that it expects wholesale revenue in the country to be down by double digits for its fiscal 2025 year, and s...
Dr. Martens' profit warning highlights U.S. consumer-confidence challenge
Dr. Martens' profit warning sent shares of the iconic shoe brand tumbling Tuesday and spotlighted consumer-spending challenges on both sides of the Atlantic.